HEALTH OF WOMAN. 2019.4(140): 64–68; doi 10.15574/HW.2019.140.64

Burka O. A., Tutchenko T. M.
Bogomolets National Medical University, Kiev
SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova NAMS of Ukraine», Kiev
ML DILA, Kyiv

Pathological vaginal discharge is one of the most common complaints in women of all ages. Today, gynecologists are increasingly faced with a problem when, in the absence of laboratory confirmation of vulvovaginal candidiasis, bacterial vaginosis and STIs, women complain of discomfort caused by vaginal secretions.
Causes of pathological vaginal discharge can be infectious and non-infectious processes and their combinations. The article analyzes the causes of the difficulties of diagnosing the of pathological vaginal discharge ethiology, demonstrates how the application of adequate volume of modern laboratory diagnostic methods in combination with understanding the multifaceted components of the inflammatory process plays crucial role in finding out the etiology of pathological vaginal secretions and the choice of optimal therapeutic tactics.
Key words: pathological vaginal dischurge, vaginal microbiota, vulvovaginal candidiasis, bacterial vaginosis, aerobic vaginitis, cytolytic vaginosis.

REFERENCES

Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2018. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 29(13):1258–72. http://journals.sagepub.com/doi/10.1177/0956462418785451. https://doi.org/10.1177/0956462418785451; PMid:30049258

Mills BB. 2017. Vaginitis: Beyond the Basics. Obstet Gynecol Clin North Am. 44(2):159–77. https://doi.org/10.1016/j.ogc.2017.02.010; PMid:28499528

Donders GGG, Ruban K, Bellen G. 2015. Selecting Anti-Microbial Treatment of Aerobic Vaginitis. Curr Infect Dis Rep. 17(5):24. http://link.springer.com/10.1007/s11908-015-0477-6. https://doi.org/10.1007/s11908-015-0477-6; PMid:25896749

POWELL AM, NYIRJESY P. 2015. New Perspectives on the Normal Vagina and Noninfectious Causes of Discharge. Clin Obstet Gynecol. 58(3):453–63. https://insights.ovid.com/crossref?an=00003081-201509000-00004. https://doi.org/10.1097/GRF.0000000000000124; PMid:26125958

Diop K, Dufour JC, Levasseur A, Fenollar F. 2019. Exhaustive repertoire of human vaginal microbiota. Hum Microbiome J. 11(January):100051. https://doi.org/10.1016/j.humic.2018.11.002

Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. 2018. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 218(6):622.e1-622.e10. https://www.sciencedirect.com/science/article/pii/S0002937818301765. https://doi.org/10.1016/j.ajog.2018.02.017. PMid:29505773 PMCid:PMC5990849

Tachedjian G, O’Hanlon DE, Ravel J. 2018. The implausible “in vivo” role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota. Microbiome. 6(1):29. https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-018-0418-3. https://doi.org/10.1186/s40168-018-0418-3; PMid:29409534 PMCid:PMC5801833

Mitchell C, Srinivasan S, Zhan X, Wu M, Reed S, Guthrie K et al. 2016. 1: Associations between serum estrogen, vaginal microbiota and vaginal glycogen in postmenopausal women. Am J Obstet Gynecol. 215(6):S827. https://linkinghub.elsevier.com/retrieve/pii/S0002937816307347. https://doi.org/10.1016/j.ajog.2016.09.028

Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. 2016. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 4(1):58. http://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-016-0203-0. https://doi.org/10.1186/s40168-016-0203-0; PMid:27802830 PMCid:PMC5088670

Kyrgiou M, Mitra A, Moscicki A-B. 2017. Does the vaginal microbiota play a role in the development of cervical cancer? Transl Res. 179:168–82. https://www.sciencedirect.com/science/article/pii/S1931524416301098. https://doi.org/10.1016/j.trsl.2016.07.004; PMid:27477083 PMCid:PMC5164950

Muzny CA, Schwebke JR. 2015. Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections: Table 1. Clin Infect Dis. 61(4):601–6. https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/civ353. https://doi.org/10.1093/cid/civ353; PMid:25935553 PMCid:PMC4607736

Mason MJ, Winter AJ. 2017. How to diagnose and treat aerobic and desquamative inflammatory vaginitis. Sex Transm Infect. 93(1):8–10. http://www.ncbi.nlm.nih.gov/pubmed/27272705. https://doi.org/10.1136/sextrans-2015-052406; PMid:27272705

Hu Z, Zhou W, Mu L, Kuang L, Su M, Jiang Y. 2015. Identification of Cytolytic Vaginosis Versus Vulvovaginal Candidiasis. J Low Genit Tract Dis. 19(2):152–5. https://insights.ovid.com/crossref?an=00128360-201504000-00014. https://doi.org/10.1097/LGT.0000000000000076; PMid:25279977

Oliveira IMF de, Giraldo PC, Amaral RLG do, Carvalho MGD de, Junior JMS. 2019. Clinical, microbiological, cytological and biochemical differences which play a critical role in the diagnosis of candidiasis and cytolytic vaginosis. Rev dos Trab Iniciação Científica da UNICAMP. (26). https://econtents.bc.unicamp.br/eventos/index.php/pibic/article/view/615. https://doi.org/10.20396/revpibic262018615

Nyirjesy P. 2014. Management of Persistent Vaginitis. Obstet Gynecol. 124(6):1135–46. http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006250-201412000-00011. https://doi.org/10.1097/AOG.0000000000000551; PMid:25415165